Open AccessTreatment of Ductal Carcinoma In Situ: Considerations for Tailoring Therapy in the Contemporary Era
Author(s) -
Anita Mamtani,
Kimberly J. Van Zee
Publication year - 2020
Publication title -
current breast cancer reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.467
H-Index - 18
eISSN - 1943-4596
pISSN - 1943-4588
DOI - 10.1007/s12609-020-00360-5
Subject(s) - medicine , surgical oncology , mastectomy , nomogram , ductal carcinoma , radiation therapy , breast cancer , oncology , cancer
Standard options for the treatment of ductal carcinoma in situ (DCIS) include breast-conserving surgery (BCS) alone; BCS with radiotherapy or endocrine therapy, or both; and mastectomy. Survival is excellent with all options, but rates of local recurrence (LR) vary, as do quality-of-life measures. Here we discuss treatment outcomes, risk factors for LR, and tools for risk estimation.